OLMEGAN

Swiss trademark · 468596 · Word mark · Deleted

Register entry

Registration number
468596
Application number
06543/1999
Status
Deleted
Type
Word mark
Filed
Jul 22, 1999
Registered
Jan 18, 2000
Published
Feb 14, 2000
Deleted
Mar 1, 2010
Reason
Not renewed
Priority
14.05.1999 JP
Source
Swissreg

Goods and services

Pharmaceuticals

Olmesartan medoxomil und Olmesartan medoxomil/hydrochlorothiazide für die Behandlung von kardiovasculären Erkrankungen inklusive Bluthochdruck, kongestive Herzinsuffizienz, diabetische Nephropathie, Arteriosklerose und Schlaganfall (Angiotensin II Rezeptor Antagonis).

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2010

    Deleted, not renewed

    Published in Swissreg on 01.03.2010

  2. Apr 22, 2002

    Partly deleted

    LGS
    5, Pharmazeutische Präparate und Substanzen, nämlich Blutdruckmittel. → 5, Olmesartan medoxomil und Olmesartan medoxomil/hydrochlorothiazide für die Behandlung von kardiovasculären Erkrankungen inklusive Bluthochdruck, kongestive Herzinsuffizienz, diabetische Nephropathie, Arteriosklerose und Schlaganfall (Angiotensin II Rezeptor Antagonis).
    International classification
    5 → 5

    Published in the SOGC no. 76 of 22.04.2002

  3. Feb 14, 2000

    Registered

    Published in the SOGC no. 31 of 14.02.2000

Parties

Holder

Sankyo Company Limited

5-1, Nihonbashi Honcho 3-chome Chuo-ku, Tokyo, JP

Agent

A. W. Metz & Co. AG in Liquidation

A.W. Metz & Co. AG

Hottingerstrasse 14, 8024 Zürich

In liquidation

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.